Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 4/2020

Inhalt (15 Artikel)

Open Access Original Article

CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γc cytokine stimulation via PI3K/mTOR axis

Cristina Capuano, Chiara Pighi, Roberta Maggio, Simone Battella, Stefania Morrone, Gabriella Palmieri, Angela Santoni, Christian Klein, Ricciarda Galandrini

Open Access Original Article

High expression of ID1 in monocytes is strongly associated with phenotypic and functional MDSC markers in advanced melanoma

Jeroen Melief, Yago Pico de Coaña, Roeltje Maas, Felix-Lennart Fennemann, Maria Wolodarski, Johan Hansson, Rolf Kiessling

Open Access Original Article

Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma

Svenja Wagener-Ryczek, Max Schoemmel, Max Kraemer, Christiane Bruns, Wolfgang Schroeder, Thomas Zander, Florian Gebauer, Hakan Alakus, Sabine Merkelbach-Bruse, Reinhard Buettner, Heike Loeser, Martin Thelen, Hans A. Schlößer, Alexander Quaas

Original Article

Enhanced glucose metabolism mediated by CD147 contributes to immunosuppression in hepatocellular carcinoma

Xiaofeng Li, Yufan Zhang, Wenchao Ma, Qiang Fu, Jianjing Liu, Guotao Yin, Peihe Chen, Dong Dai, Wei Chen, Lisha Qi, Xiaozhou Yu, Wengui Xu

Open Access Original Article

The neutrophil–lymphocyte ratio and locoregional melanoma: a multicentre cohort study

Alyss V. Robinson, Claire Keeble, Michelle C. I. Lo, Owen Thornton, Howard Peach, Marc D. S. Moncrieff, Donald J. Dewar, Ryckie G. Wade

Original Article

Treatment with an immature dendritic cell-targeting vaccine supplemented with IFN-α and an inhibitor of DNA methylation markedly enhances survival in a murine melanoma model

James T. Gordy, Kun Luo, Aakanksha Kapoor, Emily S. Kim, Samuel K. Ayeh, Petros C. Karakousis, Richard B. Markham

Open Access Original Article

Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors

Emma J. de Ruiter, Reinout H. de Roest, Ruud H. Brakenhoff, C. René Leemans, Remco de Bree, Chris H. J. Terhaard, Stefan M. Willems

Open Access Original Article

Suppressive activity of Vδ2+ γδ T cells on αβ T cells is licensed by TCR signaling and correlates with signal strength

Karin Schilbach, Naomi Krickeberg, Carlotta Kaißer, Simon Mingram, Janika Kind, Gabrielle M. Siegers, Hisayoshi Hashimoto

Original Article

PKCζ mediated anti-proliferative effect of C2 ceramide on neutralization of the tumor microenvironment and melanoma regression

Sweta Ghosh, Subir Kumar Juin, Partha Nandi, Suchandra Bhattacharyya Majumdar, Anamika Bose, Rathindranath Baral, Parames C. Sil, Subrata Majumdar

Original Article

Specific T-cell immune responses against colony-forming cells including leukemic progenitor cells of AML patients were increased by immune checkpoint inhibition

Jochen Greiner, Marlies Götz, Susanne Hofmann, Hubert Schrezenmeier, Markus Wiesneth, Lars Bullinger, Hartmut Döhner, Vanessa Schneider

Original Article

Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization

Luca Mastracci, Vincenzo Fontana, Paola Queirolo, Roberta Carosio, Federica Grillo, Anna Morabito, Barbara Banelli, Enrica Tanda, Andrea Boutros, Beatrice Dozin, Marina Gualco, Sandra Salvi, Massimo Romani, Francesco Spagnolo, Alessandro Poggi, Maria Pia Pistillo

Open Access Clinical Trial Report

First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors

Mikiya Ishihara, Yasutaka Tono, Yoshihiro Miyahara, Daisuke Muraoka, Naozumi Harada, Shinichi Kageyama, Takeshi Sasaki, Yasuhide Hori, Norihito Soga, Katsunori Uchida, Taizo Shiraishi, Eiichi Sato, Hideki Kanda, Toshiro Mizuno, Gill A. Webster, Hiroaki Ikeda, Naoyuki Katayama, Yoshiki Sugimura, Hiroshi Shiku

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.